DEAD

Serial Number

97765729

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

Filing Date

Jan 24, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OBSIDIAN THERAPEUTICS Trademark

Serial Number: 97765729

OBSIDIAN THERAPEUTICS is a trademark filed by Obsidian Therapeutics, Inc. on January 24, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Legal Representation

Attorney of Record

Olivia Maria Baratta

1,070 trademarks filed View all →

Correspondence Address

Olivia Maria Baratta KILPATRICK TOWNSEND & STOCKTON LLP

1100 Peachtree Street, Suite 2800

ATLANTA, GA 30309-4528

United States

Trademark Details

Filing Date

January 24, 2023

Registration Date

Not Registered

Published for Opposition

November 28, 2023

Goods & Services

Pharmaceutical preparations in the fields of cell therapy, gene therapy, oncology, immunotherapy, regenerative medicine, infectious disease, and the prevention and treatment of cardiovascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculoskeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, dermatological disorders and gastroenterological disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Aug 25, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Aug 25, 2025 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 2 GRANTED

Dec 6, 2024 EX2G

SOU EXTENSION 2 FILED

Dec 5, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Dec 5, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 27, 2024 EXRA

SOU EXTENSION 1 GRANTED

Jun 27, 2024 EX1G

SOU EXTENSION 1 FILED

Jun 27, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Jun 27, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jan 23, 2024 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 28, 2023 NPUB

PUBLISHED FOR OPPOSITION

Nov 28, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 8, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 20, 2023 CNSA

EXAMINER'S AMENDMENT ENTERED

Sep 20, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Sep 20, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Sep 20, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Sep 20, 2023 CNEA

ASSIGNED TO EXAMINER

Sep 14, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 14, 2023 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 13, 2023 NWOS

NEW APPLICATION ENTERED

Jan 27, 2023 NWAP

Related Trademarks

More from this Owner

CYTOTIL15

OBSIDIAN THERAPEUTICS

OBSIDIAN

More in Same Class

Serial #97765707